Magazine Article | June 1, 2023

Phase 2/3 Outsourced Spend Across Provider Types

Source: Life Science Leader

By Rebecca McAvoy, VP of Market Research, Industry Standard Research

Industry Standard Research conducted a 2022 survey with outsourcers of Phase 2/3 clinical development activities to better understand the dynamics in this space. Learning how respondents from sponsor organizations apportion their outsourced work across different provider types was of particular interest.

Overall, half of Phase 2/3 outsourcing spend goes to large, full-service CROs (51%) while one-quarter of spend (26%) goes to midsize, multi-service CROs. Small or niche service CROs and academic medical centers (AMCs) receive the remaining 14% and 9% of spend, respectively.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader